A bstract. Somatostatin (ST)-induced glucagon suppression results in hypoglycemia during rest and exercise. To further delineate the role of glucagon and interactions between glucagon and the catecholamines during exercise, we compensated for the counterregulatory responses to hypoglycemia with glucose replacement. Five dogs were run (100 m/min, 120) during exercise alone, exercise plus ST infusion (0.5 gg/kg-min), or exercise plus ST plus glucose replacement (3.5 mg/kgmin) to maintain euglycemia. During exercise alone there was a maximum increase in immunoreactive glucagon (IRG), epinephrine (E), norepinephrine (NE), FFA, and lactate (L) of 306±147 pg/ml, 360±80 pg/ml, 443±140 pg/ml, 541±173 geq/liter, and 6.3±0.7 mg/dl, respectively. Immunoreactive insulin (IRI) decreased by 10.2±4 ttU/ml and cortisol (C) increased only slightly (2.1±0.3 ug/dl). The rates of glucose production (Ra) and glucose uptake (Rd) rose markedly by 6.6±2.2 mg/ kg-min and 6.2±1.5 mg/kg-min. In contrast, when ST was given during exercise, IRG fell transiently by 130±20 pg/ml, Ra rose by only 3.6±0.5 mg/kg-min, and plasma glucose decreased by 29±6 mg/dl. The decrease in IRI was no different than with exercise alone (10.2±2.0 ,U/ ml). As plasma glucose fell, C, FFA, and L rose excessively to peaks of 5.4±1.3 ig/dl, 1,166±182 geq/liter and 15.5±7.0 mg/dl. The peak increment in E (765±287 pg/ml) coincided with the nadir in plasma glucose and was four times greater than during normoglycemic exercise. Hypoglycemia did not affect the rise in NE. The increase in Rd was attenuated and reached a peak of only 3.7±0.8 mg/kg-min. During glucose replacement, IRG decreased by 109±30 pg/ml and the IRI response did not differ from the response to normal exercise. Ra rose minimally by 1.5±0.3 mg/kg-min. The changes in E, C, Rd, and L were restored to normal, whereas the FFA response remained excessive. In all protocols increments in Ra were directly correlated to the IRG/IRI molar ratio while no correlation could be demonstrated between epinephrine or norepinephrine and Ra. In conclusion, (a) glucagon controlled -70% of the increase of Ra during exercise. This became evident when counterregulatory responses to hypoglycemia (E and C) were obviated by glucose replacement; (b) increments in Ra were strongly correlated to the IRG/IRI molar ratio but not to the plasma catecholamine concentration; (c) the main role of E in hypoglycemia was to limit glucose uptake by the muscle; (d) with glucagon suppression, glucose production was deficient but a further decline of glucose was prevented through the peripheral effects of E; (e) the hypoglycemic stimulus for E secretion was facilitated by exercise; and (f) we hypothesize that an important role of glucagon during exercise could be to spare muscle glycogen by stimulating glucose production by the liver.
Introduction
During exercise of moderate intensity, glucose uptake increases to a steady state approximately threefold above resting values (1-3), yet plasma glucose usually remains constant. To maintain euglycemia, hepatic glucose production (Ra)' must increase to match peripheral glucose uptake. Increased sympathetic drive (4) , an increase in glucagon (5, 6) and circulating catecholamines (6, 7) , and a decrease in insulin (2, 7) are all characteristic responses to exercise. All of these hormonal and neural changes are known to increase Ra (8) .
In earlier work, using somatostatin to suppress glucagon during exercise, we showed that glucagon is an important regulator of R. during both steady and nonsteady state exercise (9) . Glucagon suppression caused a drop in Ra, resulting in mild hypoglycemia. When glucagon was replaced during somatostatin infusion, normal glucose fluxes were restored. This demonstrated that the fall in Ra occurred as a result of glucagon suppression and was not due to a direct effect of somatostatin. However, it is possible that hypoglycemia-induced counterregulatory responses may have masked some of the effects of glucagon lack. Indeed, in resting dogs, selective glucagon suppression induced only a small decrease in Ra, but this decrease was much more pronounced when a euglycemic glucose clamp was established (10) . Therefore, in the present study, to quantify the responses of the main counterregulatory hormones to exercise, we measured epinephrine, norepinephrine, and cortisol in addition to immunoreactive glucagon and insulin (IRG and IRI, respectively). Five running dogs served as controls while another five dogs were run with a concurrent infusion of somatostatin, with or without a euglycemic glucose clamp. The objectives of the study were: (a) to establish the role of glucagon in regulating R. during exercise when hypoglycemia-induced counterregulation was prevented, (b) to determine whether or not moderate hypoglycemia serves as a stimulus to exaggerated release of the catecholamines and/or cortisol, (c) to delineate the metabolic consequences of any adrenergic counterregulation that may occur, and (d) not only to further delineate the role of glucagon during exercise, but also to gain a better understanding of the interactions between glucagon and the catecholamines in the regulation of glucose fluxes during exercise.
Methods
Experimental animals. 10 Tracer methods. In all experiments, 5 gCi/ml of [3-3H] glucose (New England Nuclear, Lachine, Quebec) was infused at a constant rate (0.094 ml/min). A priming dose, equivalent to the amount infused in 140 min was given at the beginning of each experiment. The method of measurement of R. and Rd for endogenous glucose has been described previously (I 1) and extensively validated (12, 13 
Results
Plasma glucose concentrations and glucose turnover. Fig. 2 A illustrates the effect of the three protocols on plasma glucose concentration. In the control experiments, plasma glucose concentration remained constant throughout exercise. Somatostatin infusion during exercise resulted in hypoglycemia. Plasma glucose fell transiently with a nadir at 30 min of 62±6 mg/dl. Glucose values were significantly lower from 10 to 40 min (P < 0.05) after the onset of exercise plus ST than those seen with exercise alone. Glucose replacement during somatostatin infusion restored the plasma glucose concentration to normal levels during exercise. However, after exercise when muscular glucose utilization decreased, hyperglycemia was noted.
Kinetic analysis demonstrated that the hypoglycemia seen when ST was infused during exercise was due to a significantly smaller increase in endogenous glucose production than that seen during exercise alone (Fig. 2 B) . With normal exercise Ra rose to a peak of 11.06±2.15 mg/kg-min after 60 min of (Fig. 3 B) . Levels fell by 10 .2±4.0 MU/ml during exercise alone. There were no significant differences in IRI values in any of the three studies.
When the results of the three protocols were grouped together R. was found to be significantly correlated with IRG (r = 0.61, P < 0.0001) as well as to the molar ratio of IRG to IRI (r = 0.76, P < 0.0001, Fig. 4 to 50 min (P < 0.05 to 0.005). Norepinephrine increased fourfold and this was not affected by hypoglycemnia (Fig. 5 C) . Individual epinephrine data during rest and exercise were plotted against the plasma glucose values (Fig. 6 ). It can be seen that the epinephrine response to exercise was enhanced with a very modest decrease in plasma glucose. Very epinephrine values were reached at glucose levels < 85 mg/dl.
R. was not significantly correlated to either epinephrine or norepinephrine under any of the three exercise conditions. Metabolites. The lactate levels during the three exercise protocols are shown in Fig. 7 A. During exercise plus ST, lactate increased by 15.5±3.8 mg/dl at 30 min but by only 6.8±1.9 mg/dl during exercise alone and 6.6±1.9 mg/dl during exercise plus ST plus G. Lactate values during hypoglycemic exercise were significantly higher than in the two normoglycemic groups (P < 0.05 to 0.01). Fig. 7 B shows that during exercise plus ST, FFA levels were significantly higher than those seen with exercise alone (P < 0.025 to 0.005). Surprisingly, prevention of hypoglycemia failed to correct this increase as FFA values remained higher than in the control studies (P < 0.05 to 0.025).
Discussion
This study not only illustrates the important role of glucagon in exercise but also delineates the nature of the counterregulatory responses that are triggered when glucagon is suppressed. In a previous study we showed that suppression of glucagon, either at the onset of exercise or during steady state exercise, resulted in suppression of R. and transient hypoglycemia (9) . However, the role and nature of counterregulation during hypoglycemia was not examined. Also, the full metabolic impact of glucagon suppression could only be revealed if counterregulatory responses were prevented along with glucagon suppression (10) . In the resting dog, isolated glucagon deficiency resulted in approximately a 1.5-3.0 mg/kg-min decrement in Ra when glucose was clamped (10) . In our studies, glucagon suppression lowered R. 4 .8 mg/kg-min, suggesting that the exercise-induced increment in Ra had been affected as well as base-line Ra. However, since insulin is reduced with exercise, hepatic sensitivity to glucagon will probably be increased (20) (21) (22) . Thus, although we have clearly shown that the presence of glucagon is important we cannot define quantitatively the relative importance of basal vs. the extra glucagon released during exercise.
To accurately assess the effects of glucagon suppression during exercise in these studies requires that somatostatin does not have an appreciable direct effect on glucose fluxes. In earlier work, we showed (9) that when endogenous glucagon release was suppressed with somatostatin, glucagon replacement (4 or 6 ng/kg-min) normalized plasma glucose levels, glucose production, and uptake. Thus, during somatostatin infusion, glucose replacement in this paper and glucagon replacement in our previous work yielded the same results with respect to total glucose appearance and glucose uptake. In the present work, despite receiving exactly the same somatostatin infusion, excess release of epinephrine and cortisol were only seen in the group allowed to become hypoglycemic. Therefore, it is unlikely that any of the changes we observed are a direct result of somatostatin, but instead, a manifestation of glucagon suppression.
In man, acute suppression of glucagon by somatostatin also resulted in hypoglycemia during exercise (23). However, when ST was infused 2 h before and during exercise, the increase in splanchnic glucose output was not attenuated. This could be explained by the fact that glucagon levels were still substantial, and the liver had been exposed to low IRI levels for a prolonged period of time. These observations in man were similar to our observations in depancreatized dogs in which the mere presence of glucagon was sufficient to control hepatic glucose production during exercise (2 exercise in man and dog. In dog, glucagon increases gradually with the onset of exercise (in these studies glucagon doubled after 90 min). In man, glucagon only increases in strenuous or prolonged exercise (5, 6) . With ST infusion during exercise, cortisol and epinephrine levels were both higher than during normoglycemic exercise (Fig. 5 A and B) , whereas norepinephrine was not significantly different in any of the three protocols (Fig. 5C ). These increases in epinephrine and cortisol occurred in response to the hypoglycemia that accompanied glucagon suppression, since these responses were alleviated when euglycemia was maintained during somatostatin infusion. The first significant change in epinephrine during exercise plus ST occurred at 10 min with a fall in blood glucose of only 8 mg/dl. A similar decrease in glucose during rest does not lead to an increase in catecholamines (24) (25) (26) (27) (28) . For example, in studies from our laboratory, epinephrine increased in normal resting dogs during insulininduced hypoglycemia only when plasma glucose fell <60 mg/ dl (22, 28 ). An increase in epinephrine has been observed with a moderate fall in plasma glucose (27) , but this only occurred after 30 min of continuous exposure to this degree of hypoglycemia. Thus, it appears that exercise can change the threshold for glucose, which generates a signal leading to an increased activity of the adrenal medulla. The fact that we observed a disproportionate increase in epinephrine but not in norepinephrine during hypoglycemia indicates that there may be separate control mechanisms for changes in adrenal medullary function and for changes in sympathetic drive. Cortisol also increases with moderate hypoglycemia in resting conscious dogs (26, 29) and this increase is similar to that observed during hypoglycemic exercise. Although the peak epinephrine value was attained at the same time as the nadir in plasma glucose, cortisol did not reach a peak until 20 min after this point. The time course of these responses could be consistent with a role for epinephrine in emergency situations and for cortisol in adaptation to stress. Recently, it has been suggested that the interplay between corticotropin and some of the brain neuropeptides can generate the selective hormonal responses in different stress situations (30) .
To more clearly delineate the role of glucagon in dynamics of glucose production, we infused somatostatin with and without glucose replacement. In both groups receiving somatostatin, after an early nadir, glucagon rose at a rate similar to that seen in the controls, but still remaining well below the normal glucagon response to exercise. This transience is prob- Plasma Glucose mg/dl ably a result of the characteristic adrenergic stimulation of glucagon seen with exercise (31) . Glucose replacement abolished the compensatory hormonal responses seen when the dogs were allowed to become hypoglycemic during exercise, thereby isolating the effects of glucagon suppression from those of other counterregulatory hormones. The level of glycemia per se may affect Ra directly (32, 33) or indirectly through altered secretion of pancreatic hormones (34, 35) , which could in turn affect R.. In this study, as in a previous study (9) , there was an increase in Ra with ST infusion during exercise but this was much smaller than with exercise alone. This suppression was due to a delayed onset of the increase in Ra. With the infusion of ST plus G during exercise, endogenous Ra was suppressed an additional 2.0 mg/kg-min with a similar time course (Fig. 2 B) . Thus, the full impact of glucagon suppression on R. is only revealed when the counterregulatory responses are prevented, as was also shown in resting dogs (10 (21) . This difference can, in part, be explained because glucagon increases progressively during exercise while constant glucagon levels were maintained in the resting alloxandiabetic dogs. It is conceivable, however, that the lack of hyperglycemia and perhaps other unknown factors also con- tribute to the sustained effect of the glycogenolytic hormones during exercise.
Correlating Ra with its potential hormonal regulators revealed a strong and highly significant positive correlation with the IRG/IRI molar ratio in all three experimental protocols (Fig. 4) . This correlation was observed whether the results of the three experimental protocols in the present study were pooled or were considered independently. Although IRG alone was significantly correlated to Ra when the data of the three protocols were pooled, independent analysis of each protocol showed a significant correlation only in control experiments. On the other hand, there was no significant correlation between Ra and the catecholamines. Thus, it appears that IRG/IRI is the strongest determinant of Ra in exercise.
With exercise plus ST, FFA's were significantly elevated when compared with values for exercise alone (Fig. 7 B) possibly due to excessive epinephrine release (36, 37 Plasma lactate was increased to a greater extent during hypoglycemic than during normoglycemic exercise (Fig. 7 A) . Since the increase in lactate occurred while glucose utilization was attenuated during hypoglycemia, the elevated lactate levels most probably reflect an increase in muscle glycogenolysis. 
